Works matching IS 0195668X AND DT 2024 AND VI 45 AND IP 13


Results: 21
    1
    2
    3

    Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.

    Published in:
    European Heart Journal, 2024, v. 45, n. 13, p. 1104, doi. 10.1093/eurheartj/ehae069
    By:
    • Windecker, Stephan;
    • Gilard, Martine;
    • Achenbach, Stephan;
    • Cribier, Alain;
    • Delgado, Victoria;
    • Deych, Nataliya;
    • Drossart, Inga;
    • Eltchaninoff, Hélène;
    • Fraser, Alan G;
    • Goncalves, Alexandra;
    • Hindricks, Gerhard;
    • Holborow, Richard;
    • Kappetein, Arie Pieter;
    • Kilmartin, John;
    • Kurucova, Jana;
    • Lüscher, Thomas F;
    • Mehran, Roxana;
    • O'Connor, Donal B;
    • Perkins, Mark;
    • Samset, Eigil
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.

    Published in:
    European Heart Journal, 2024, v. 45, n. 13, p. 1173, doi. 10.1093/eurheartj/ehad889
    By:
    • Sayah, Neila;
    • Bhatt, Deepak L;
    • Miller, Michael;
    • Brinton, Eliot A;
    • Jacobson, Terry A;
    • Ketchum, Steven B;
    • Jiao, Lixia;
    • Pineda, Armando Lira;
    • Doyle, Ralph T;
    • Tardif, Jean Claude;
    • Ballantyne, Christie M;
    • Steg, Ph Gabriel
    Publication type:
    Article
    11
    14
    15
    16
    17
    18
    19
    20
    21

    Discontinuation vs. continuation of renin–angiotensin system inhibition before non-cardiac surgery: the SPACE trial.

    Published in:
    European Heart Journal, 2024, v. 45, n. 13, p. 1146, doi. 10.1093/eurheartj/ehad716
    By:
    • Ackland, Gareth L;
    • Patel, Akshaykumar;
    • Abbott, Tom E F;
    • Begum, Salma;
    • Dias, Priyanthi;
    • Crane, David R;
    • Somanath, Sameer;
    • Middleditch, Alexander;
    • Cleland, Stuart;
    • Arroyo, Ana Gutierrez del;
    • Brealey, David;
    • Pearse, Rupert M;
    • investigators, the Stopping Perioperative ACE-inhibitors or angiotensin-II receptor blockers (SPACE) trial
    Publication type:
    Article